DrugPatentWatch Week in Review
Drug Patent Watch
JUNE 29, 2024
Patent Expirations and Generic Competition This week saw several major blockbuster drugs facing patent expirations, potentially opening the market for […] Source
Sat.Jun 29, 2024
98 
Which pharmaceutical companies have the most drug patents in Australia?
Drug Patent Watch
JUNE 29, 2024
This chart shows the pharmaceutical companies with the most patents in Australia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.
New tentative approval for Alembic drug dabigatran etexilate mesylate
Drug Patent Watch
JUNE 29, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.
Let's personalize your content